DuringaninterviewwithSFC,AnnaVanAcker,PresidentofMSDinChinaandSeniorVice-PresidentofMSD,reaffirmedMSD’scontinuousinvestmentandsupportforHealthyChina2030.
MSDhasbeendevelopinginChinaformorethan30years.AckerhighlightedthreeenginesofMSD’sdevelopmentinChinawhicharearoundR&D,manufacturingandcommercialoperations.SheemphasizedthatMSDwillcontinuetoinvestinpublichealth,andtotacklethehugeunmetmedicalneedsinChina.